×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Amid a Crisis of Mental Health in Mexico, a Donation Fills Gaps in Care

In partnership with Pfizer, Direct Relief has worked to increase access to mental health treatment across Mexico.

News

Mexico

Direct Relief works to meet medical needs in Mexico during emergencies and also as part of ongoing efforts to support the health system. The organization recently worked to provide critical mental health medications to patients in need. (Direct Relief photo)
By Talya Meyers

Since the Covid-19 pandemic, psychologist Brenda Rodriguez Aguilar has seen mental health needs increase by 30% in Mexico. The supply of medication hasn’t always kept up with the need.

Aguilar coordinates mental health care at the Clínica de Atención al Trastorno por Estrés Postraumático, or ISSEMyM, in the State of Mexico. The clinic focuses on post-traumatic stress, often from gender-based violence, among the state’s government workers. When patients are referred to the clinic, they are screened for mental health disorders, and psychiatrists work in consultation with psychologists to develop a care plan that includes sourcing or covering the cost of mental health medications.

About 70% of her patients are women, Aguilar said. “Women are more affected by social factors,” such as additional, unpaid labor and intimate partner violence, she explained through a translator. Men are also less likely to seek care for mental health conditions, which are stigmatized in Mexico, as in countries around the world.

Desvenlafaxine, a medication often used to treat major depressive disorder and related mental health conditions, is a key component of care for many of the patients at ISSEMyM. But Aguilar said these types of medicines aren’t always available to patients. Certain treatments, specifically serotonin-norepinephrine reuptake inhibitors, or SNRIs, like desvenlafaxine and selective serotonin reuptake inhibitors, or SSRIs, are widely needed.

“This is common in the health services,” Aguilar told Direct Relief.

To fill these essential gaps, Direct Relief’s Mexico office is working closely with biopharmaceutical company Pfizer to supply desvenlafaxine to five mental health partners across Mexico.

While mental health has worsened worldwide since the pandemic began, Mexico has been hit particularly hard, said Jonathan Mangotich, a corporate engagement manager at Direct Relief Mexico.

Mexico’s Ministry of Health reports that 3.6 million adults are currently experiencing depression – a significant increase from pre-pandemic numbers.

Direct Relief’s program in partnership with Pfizer is designed to increase access to essential mental health care for vulnerable individuals, Mangotich said, with a particular focus on treating widespread anxiety and depression.

He estimates that the donation of desvenlafaxine has supported about 700 patients across Mexico.

“Our efforts to create greater access to mental healthcare are driven by the understanding that mental well-being is fundamental to overall health and quality of life,” a Pfizer representative told Direct Relief. “Through strategic partnerships, innovative programs, and a focus on affordability and equity, Pfizer is working to ensure that individuals, regardless of their socioeconomic status or geographic location, can access the mental health support they require.”

“When Pfizer donated this medicine, it contributed significantly,” Aguilar said. “Women were suffering in particular” without it.

She explained that menopause and other women’s health concerns can affect depression and other mental health conditions. “This pill helps them with just that,” she said.

Aguilar explained that by the time ISSEMyM screens new patients for mental health symptoms, a general practitioner or other provider has already reported concerns or identified a potential need for mental health intervention through screening. At ISSEMyM, the goal is to identify how urgent the needs are – there are three tiers, the highest of which indicates that a patient is at imminent risk of self-harm – and develop an effective treatment plan.

When medicines aren’t available, that plan can be affected, Aguilar said.

“When there is no economic support for the purpose of medication…that leads to disengagement of treatment and care,” she said.

Filed Under: , , , ,

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.